UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 128

Sortiert nach

2SPD-036 Centralised propofol reconditioning procedure during COVID-19

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A9-A10

2021

Link zum Volltext

Verfügbarkeit prüfen

6ER-028 Baricitinib against severe COVID-19: effectiveness and safety in hospital care

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A169-A169

2021

Link zum Volltext

Verfügbarkeit prüfen

2SPD-046 Organisational challenges of the pharmacy service as a consequence of the COVID-19 pandemic

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A14-A14

2021

Link zum Volltext

Verfügbarkeit prüfen

5PSQ-221 Safety profile of experimental therapies used in the COVID-19 pandemic based on data from the National Minimum Data Set

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A163-A163

2021

Link zum Volltext

Verfügbarkeit prüfen

4CPS-405 Strongyloides stercoralis prophylaxis with ivermectin in COVID-19 patients

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A115-A116

2021

Link zum Volltext

Verfügbarkeit prüfen

4CPS-313 Experience of the use of baricitinib in COVID-19 pneumonia

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A71-A71

2021

Link zum Volltext

Verfügbarkeit prüfen

5PSQ-214 ‘Unit dose’: clinical risk management of COVID-19 patients treated with hydroxychloroquine

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A160-A160

2021

Link zum Volltext

Verfügbarkeit prüfen

2SPD-031 Subgroup analysis about efficacy of early use of remdesivir in COVID-19

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A7-A7

2021

Link zum Volltext

Verfügbarkeit prüfen

2SPD-029 Off-label drugs: use analysis and pharmacoepidemiology in a COVID centre in Rome

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A6-A6

2021

Link zum Volltext

Verfügbarkeit prüfen

2SPD-047 New requirements of outpatients in the COVID-19 era: adapting pharmaceutical care

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A14-A15

2021

Link zum Volltext

Verfügbarkeit prüfen

4CPS-395 Pharmacy service’s adaptation to the COVID-19 pandemic: telepharmacy and home drug delivery

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A111-A111

2021

Link zum Volltext

Verfügbarkeit prüfen

4CPS-317 Immunosuppressive treatment management in a cohort of hospitalised solid organ recipients affected by COVID-19

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A73-A73

2021

Link zum Volltext

Verfügbarkeit prüfen

4CPS-333 Treating multiple sclerosis patients with infusion of disease modifying treatments during the COVID-19 pandemic

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A81-A81

2021

Link zum Volltext

Verfügbarkeit prüfen

4CPS-331 Inflammatory parameter analysis in severe COVID-19 patients treated with tocilizumab

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A80-A80

2021

Link zum Volltext

Verfügbarkeit prüfen

4CPS-384 Potential drug related problems in the time of COVID-19

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A105-A106

2021

Link zum Volltext

Verfügbarkeit prüfen

5PSQ-213 Hospital admissions after discharge from the emergency department to home with COVID-19 treatment

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A159-A160

2021

Link zum Volltext

Verfügbarkeit prüfen

5PSQ-168 Interest and implementation of rapid daratumumab infusion during the health crisis

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A138-A139

2021

Link zum Volltext

Verfügbarkeit prüfen

5PSQ-190 Experience and satisfaction of outpatients in the development of a programme for home medication delivery

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A149-A149

2021

Link zum Volltext

Verfügbarkeit prüfen

4CPS-260 Analysis of drugs interactions between coronavirus (COVID-19) antiviral treatment and concomitant medication

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A45-A45

2021

Link zum Volltext

Verfügbarkeit prüfen

4CPS-149 Hospital at home COVID unit: multidisciplinary strategies

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A78-A79

2022

Link zum Volltext

Verfügbarkeit prüfen

6ER-025 Real-life use of remdesivir in hospitalised COVID-19 patients with severe pneumonia: an observational study from an Italian university hospital

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A176-A176

2022

Link zum Volltext

Verfügbarkeit prüfen

5PSQ-042 Toxicity of remdesivir as treatment of non-critically ill COVID-19 patients

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A132-A132

2022

Link zum Volltext

Verfügbarkeit prüfen

4CPS-249 Eltrombopag for treatment of autoimmune thrombocytopenia associated with COVID-19 vaccine: a case report

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A111-A111

2022

Link zum Volltext

Verfügbarkeit prüfen

4CPS-227 Feedback from a region on the use of e-therapeutic patient education during the health crisis: high-speed interviews

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A105-A105

2022

Link zum Volltext

Verfügbarkeit prüfen

6ER-014 Analysis of the evolution of interleukin-6 in COVID-19 patients after being treated with dexamethasone

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A171-A172

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 128

Suche als RSS-Feed

Aktive Filter

KollektionBMJ Journals

Zeitschrift / SerieBmj Global Health

Zeitschrift / SerieEuropean Journal Of Hospital Pharmacy. Science And Practice

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(128)
Mit Volltextzugriff
(126)

Publikationsform

Artikel
(128)

Sprache

Englisch
(128)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Coronaviruses
(127)
Covid-19
(111)
Conflicts Of Interest
(74)
Pandemics
(58)
Life Sciences & Biomedicine
(53)
Pharmacology & Pharmacy
(53)
Science & Technology
(53)
Severe Acute Respiratory Syndrome Coronavirus 2
(41)
Drug Stores
(32)
Patients
(29)
Humans
(26)
Pharmacists
(23)
Clinical Medicine
(19)
Pharmacy
(19)
Covid-19 Vaccines
(17)
Hospitals
(17)
Pneumonia
(15)
Critical Care
(13)
Drug Dosages
(13)
Public Health
(13)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Electronic Journals Library - Freely accessible e-journals
(128)
Lippincott E Journal Collection
(128)
BMJ
(128)
MEDLINE
(30)

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

2SPD-036 Centralised propofol reconditioning procedure during COVID-19

6ER-028 Baricitinib against severe COVID-19: effectiveness and safety in hospital care

2SPD-046 Organisational challenges of the pharmacy service as a consequence of the COVID-19 pandemic

5PSQ-221 Safety profile of experimental therapies used in the COVID-19 pandemic based on data from the National Minimum Data Set

4CPS-405 Strongyloides stercoralis prophylaxis with ivermectin in COVID-19 patients

4CPS-313 Experience of the use of baricitinib in COVID-19 pneumonia

5PSQ-214 ‘Unit dose’: clinical risk management of COVID-19 patients treated with hydroxychloroquine

2SPD-031 Subgroup analysis about efficacy of early use of remdesivir in COVID-19

2SPD-029 Off-label drugs: use analysis and pharmacoepidemiology in a COVID centre in Rome

2SPD-047 New requirements of outpatients in the COVID-19 era: adapting pharmaceutical care

4CPS-395 Pharmacy service’s adaptation to the COVID-19 pandemic: telepharmacy and home drug delivery

4CPS-317 Immunosuppressive treatment management in a cohort of hospitalised solid organ recipients affected by COVID-19

4CPS-333 Treating multiple sclerosis patients with infusion of disease modifying treatments during the COVID-19 pandemic

4CPS-331 Inflammatory parameter analysis in severe COVID-19 patients treated with tocilizumab

4CPS-384 Potential drug related problems in the time of COVID-19

5PSQ-213 Hospital admissions after discharge from the emergency department to home with COVID-19 treatment

5PSQ-168 Interest and implementation of rapid daratumumab infusion during the health crisis

5PSQ-190 Experience and satisfaction of outpatients in the development of a programme for home medication delivery

4CPS-260 Analysis of drugs interactions between coronavirus (COVID-19) antiviral treatment and concomitant medication

4CPS-149 Hospital at home COVID unit: multidisciplinary strategies

6ER-025 Real-life use of remdesivir in hospitalised COVID-19 patients with severe pneumonia: an observational study from an Italian university hospital

5PSQ-042 Toxicity of remdesivir as treatment of non-critically ill COVID-19 patients

4CPS-249 Eltrombopag for treatment of autoimmune thrombocytopenia associated with COVID-19 vaccine: a case report

4CPS-227 Feedback from a region on the use of e-therapeutic patient education during the health crisis: high-speed interviews

6ER-014 Analysis of the evolution of interleukin-6 in COVID-19 patients after being treated with dexamethasone

Aktive Filter

Suchergebnisse filtern